Navigation Links
A crystal ball for brain cancer?
Date:7/29/2009

UCLA researchers have uncovered a new way to scan brain tumors and predict which ones will be shrunk by the drug Avastin -- before the patient ever starts treatment. By linking high water movement in tumors to positive drug response, the UCLA team predicted with 70 percent accuracy which patients' tumors were the least likely to grow six months after therapy.

Bronnie McNabb, 57, considers himself lucky. When his aggressive brain cancer returned after chemotherapy and radiation, his UCLA doctor prescribed the off-label use of Avastin, a drug shown to quell cancers in the breast, colon and lung.

One month later, McNabb's tumors had shrunk by 95 percent. Subsequent brain scans show no trace of his cancer at all. The former marathon runner, ordained minister and father of two says he hasn't felt this good since his diagnosis last winter.

In welcome news for patients like McNabb, the U.S. Food and Drug Administration approved the use of Avastin last month for the treatment of brain cancer. The powerful drug shrinks tumors by choking off their blood supply. Half of patients don't respond to the therapy, though, exposing them to unnecessary side effects and medication costing up to $10,000 per month.

Now UCLA scientists have uncovered a new way to image tumors and forecast which patients, like McNabb, are most likely to benefit from Avastin before starting a single dose of treatment. The findings are published in this month's issue of the journal Radiology.

"Avastin is an expensive drug, yet only 50 percent of patients with recurring brain cancers respond to it," said lead author Dr. Whitney Pope, assistant professor of radiological sciences at the David Geffen School of Medicine at UCLA. "Until now, there has been no good way to identify these patients in advance. Our work is the first to suggest that we can predict which tumors will respond before the patient ever starts therapy."

Pope and h
'/>"/>

Contact: Elaine Schmidt
eschmidt@mednet.ucla.edu
310-794-2272
University of California - Los Angeles
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
2. Unveiling the structure of microcrystals
3. Liquid crystal phases of tiny DNA molecules point up new scenario for first life on Earth
4. Scientists find missing evolutionary link using tiny fungus crystal
5. New clues to how proteins dissolve and crystallize
6. Crystal (eye) ball: Study says visual system equipped with future seeing powers
7. Scientists demonstrate the sharpest measurement of ice crystals in clouds
8. Photonic crystal biosensors detect protein-DNA interactions
9. Bare bones of crystal growth: Biomolecules enhance metal contents in calcite
10. Heavy pyridine crystallizes differently
11. A crystal clear view of chalk formation

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A crystal ball for brain cancer?
A crystal ball for brain cancer?
(Date:11/19/2009)...c diversity in maize, also known as corn, research...e map that should pave the way to significant impr..., fuel, animal feed and fiber around the world. ,... a haplotype map, charts genetic diversity and rec... maize. The research team, led by U.S. Department ...
(Date:11/19/2009)...09 -- Sustainable farming, initially adopted to pr...so play a role in maintaining a healthy climate, a...y,s Oak Ridge and Los Alamos national laboratories...arge potential of the earth,s soils to sequester c...ractices could greatly reduce U.S. carbon emission...
(Date:11/19/2009)... maize has identified thousands of diverse genes i... New techniques may allow breeders and researchers...le traits and create new varieties that were not e...19 issue of Science , the researchers, whose seni...d the first map of haplotypes sets of closely lin...
Breaking Biology News(10 mins):ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3New map of variation in maize genetics holds promise for developing new varieties 2Actuaries 3A Health Care Reform Must Address Costs 52038 1Actuaries 3A Health Care Reform Must Address Costs 52038 2MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 52034 1MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 52034 2MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 52034 3MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 52034 4Fetal Alcohol Disorders Often Misdiagnosed as ADHD 52030 1Fetal Alcohol Disorders Often Misdiagnosed as ADHD 52030 2
...search Associate at the Stowers Institute for Medi... Institute Investigator and an investigator with t...ted that the long-studied family of transcription ...ion during the formation of the vertebral precurso... which were published in the March 7 issue of Deve...
...ultures and in most mammals, males are usually mor... simple to blame male hormones, like testosterone,...t,s in our genes, too. , Indeed such social behavi...arch on mice by neuroscientists at the University ...x chromosomes, XX versus XY, are also responsible ...
...al trade in the Roti Island snake-necked turtle, f...all but extinct in the wild. Exotic pet enthusias...ing the illegal trade for the turtle, often withou...se. No legal trade of this species has been allow...life trade monitoring network of WWF and IUCN, "Tr...
Other Biology News:Stowers scientists demonstrate mechanism of vertebral formation 2Sex chromosome genes influence aggression andmaternal behavior, say UVa researchers 2Illegal trade is propelling rare turtle toward extinction, new report 2
(Date:11/20/2009)...ATTLE, Nov. 20 Cell Ther...ced today that the Ninth Circuit Court of Appeals ...t CTI should be allowed to pursue all of its claim... the District Court for trial. CTI filed a compla...ty reimbursement consultant for CTI,s product TRIS...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr...“The Role of Process Analytical Technology (...o; on December 1, 2009. , ... of Process Analytical Technology (PAT) in Green C...r 1, Process Analytical Technology (PAT) case stud...
(Date:11/19/2009)...GEN, Nov. 19 Danish Prince Joachim...c ethanol plant in Kalundborg, Denmark, on Wednesd...s first and largest 2nd generation ethanol demonst...es are used in the plant,s innovative process for ...Danisco, was the first to market with commercial e...
(Date:11/19/2009)...LT, N.Y., Nov. 19 Dr. Mate Hidvegi... responds to a press release issued on November 17...pany for making false and self-serving statements ..., Dr. Hidvegi stated from his office in Budapes...arch on Avemar does not apply to AveULTRA, www.a...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2
...ON, N.J., May 28 Quest Diagnostics scientists wil...ffect of genomic abnormalities on the diagnosis an...prostate cancer during the 45th Annual Meeting of ...scheduled for May 29 through June 2 in Orlando, FL... the world,s leading provider of diagnostic testin...
...AIN VIEW, Calif., May 28 Clontech Laboratories, I... today announced the upcoming (June 1, 2009) relea...n reagents. These novel transfection reagents are ...uperior transfection efficiency of plasmid DNA int...tions can be carried out entirely in the presence ...
...es to be presented on safety and efficacy of SpyGl...es throughout pancreatico-biliary system , , NATI...NYSE: BSX ) today announced that 14 abstracts an...SpyGlass(R) Direct Visualization System will be pr...runs from May 30 to June 4 in Chicago. , , "The ...
Other Biology Technology:Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 2Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 3Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 4Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 5Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents 2Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 2Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 3Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 4Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 5Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 6
Goat Anti-ORC2L Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human B3GALT2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Mouse Anti-Human XPC Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Film Exposure Folders from Upstate
Biology Products: